Connection

Marco Metra to Prospective Studies

Back to Details
This is a "connection" page, showing publications Marco Metra has written about Prospective Studies.
Marco Metra
Connection Strength
0.214
Prospective Studies
  1. The role of type 2 diabetes mellitus on hypertensive-related aortic stiffness. Echocardiography. 2018 06; 35(6):798-803.
    View in: PubMed
    Score: 0.030
  2. Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF. Int J Cardiol. 2018 02 15; 253:91-96.
    View in: PubMed
    Score: 0.030
  3. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568.
    View in: PubMed
    Score: 0.009
  4. Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail. 2018 09; 20(9):1269-1277.
    View in: PubMed
    Score: 0.008
  5. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018 03 01; 57(3):441-450.
    View in: PubMed
    Score: 0.008
  6. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. Int J Cardiol. 2018 02 15; 253:84-90.
    View in: PubMed
    Score: 0.008
  7. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology (Oxford). 2018 02 01; 57(2):370-381.
    View in: PubMed
    Score: 0.008
  8. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF. J Am Coll Cardiol. 2018 01 30; 71(4):386-398.
    View in: PubMed
    Score: 0.008
  9. Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF. Eur J Heart Fail. 2018 05; 20(5):923-930.
    View in: PubMed
    Score: 0.008
  10. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis. 2018 04; 77(4):563-570.
    View in: PubMed
    Score: 0.008
  11. High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction. Drug Des Devel Ther. 2017; 11:3425-3434.
    View in: PubMed
    Score: 0.007
  12. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2018 02; 20(2):304-314.
    View in: PubMed
    Score: 0.007
  13. The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis. J Am Coll Cardiol. 2017 Oct 24; 70(17):2128-2136.
    View in: PubMed
    Score: 0.007
  14. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality. Circulation. 2018 03 27; 137(13):1320-1330.
    View in: PubMed
    Score: 0.007
  15. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail. 2018 04; 20(4):700-710.
    View in: PubMed
    Score: 0.007
  16. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27; 69(25):3029-3039.
    View in: PubMed
    Score: 0.007
  17. Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. Eur J Heart Fail. 2017 10; 19(10):1284-1293.
    View in: PubMed
    Score: 0.007
  18. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2017 Mar 01; 38(9):648-660.
    View in: PubMed
    Score: 0.007
  19. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. Eur J Heart Fail. 2017 05; 19(5):627-634.
    View in: PubMed
    Score: 0.007
  20. Prognostic role of ß-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail. 2017 07; 19(7):904-914.
    View in: PubMed
    Score: 0.007
  21. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Ann Rheum Dis. 2017 Jul; 76(7):1207-1218.
    View in: PubMed
    Score: 0.007
  22. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Eur J Heart Fail. 2017 08; 19(8):1001-1010.
    View in: PubMed
    Score: 0.007
  23. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol. 2013 Sep 10; 167(6):2710-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.